By Stefan Armstrong, Partner, AIS, Greater Than...
Ad Right Top
There is creative life outside Manhattan. Yes,...
Abbott Laboratories (ABT.N) on Thursday said it...
June 2015 Focus: Top 100 Biotech & DTC
- Threat and Expense of Antitrust Litigation Grows in the Health Care Sector; ACE Report Identifies Due Diligence Practices to Help Mitigate Risk
- 21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry
- The Future of Personalized Health Marketing
Ad Right Bottom
- Regeneron’s George Yancopoulos Becomes Pharma’s First Billionaire R&D Chief
- Some serious drug side effects not told to FDA within 15 days
- Regeneron and Sanofi Announce FDA Approval of Praluent (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients